United States Últimas notícias

BioXcel Therapeutics (NASDAQ:BTAI) announced that the U.S. Food and Drug Administration has formally accepted a supplemental New Drug Application for its lead neuropsychiatric drug, providing a clear regulatory catalyst as the company manages tightening capital constraints.

Traws Pharma (NASDAQ:TRAW) reported a net loss for the first quarter of 2026 as the company aggressively scaled up investments in its respiratory antiviral pipeline, pivoting away from the profitable metrics recorded in the prior year's opening period.

Protara Therapeutics (NASDAQ:TARA) reported updated 12-month interim data from the Cohort A arm of its Phase 2 ADVANCED-2 clinical trial, demonstrating sustained tumor clearance and a favorable safety profile for its lead oncology candidate.

PowerBank (NASDAQ:SUUN) reported a significant expansion in its underlying profit margins and a strengthened balance sheet for the first nine months of fiscal year 2026, driven by systematic execution of its North American clean energy project pipeline.

Sébastien Page, T. Rowe Price CIO and head of global multi-asset, talks about the challenges around hedging against inflation risk. He says the main risk in financial markets is the "collision course between inflation and Fed policy." He speaks on "Bloomberg Surveillance."

Indaptus Therapeutics (NASDAQ:INDP) announced a sweeping re-evaluation of its core developmental pipeline and resource allocation alongside a significant leadership transition, signaling a strategic pivot as the company faces tightening liquidity constraints.

Purple Biotech (NASDAQ:PPBT) reported its financial and operational results for the first quarter of 2026, highlighting clinical milestones within its immunotherapy pipeline and a stabilized bottom line supported by non-operating income.

President Donald Trump heads home after a two day summit with China's Xi Jinping in Beijing. Bloomberg's Annmarie reports on what they've accomplished and what's next.

The Board of Directors of Genco Shipping & Trading (NYSE:GNK) has unanimously rejected an unsolicited tender offer from Diana Shipping to acquire all outstanding shares of the company for $23.50 per share in cash, setting up a high-stakes corporate standoff in the global maritime sector.

Tenaya Therapeutics (NASDAQ:TNYA), a clinical-stage biotechnology company developing gene therapies for heart disease, reported positive interim data from the first two cohorts of its ongoing RIDGE-1 Phase 1b/2 trial of TN-401 in patients with PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC).

H World Group (NASDAQ:HTHT) reported double-digit revenue and turnover growth for the first quarter of 2026, capitalizating on persistent leisure and business travel demand across its sprawling multi-brand hospitality network.

Seritage Growth Properties (NYSE:SRG) reported a widening net loss for the first quarter of 2026, driven by significant asset impairment charges, while management continues to negotiate the restructuring of its remaining corporate debt ahead of a summer deadline.